Medication
New data on ADHD study drug NS2359
NS2359 is a mixed monoamine reuptake inhibitor. A study looked at the efficacy of NS2359 versus placebo in a double-blind randomized trial. There was no statistical difference in the total ADHD-RS scale score between those taking NS2359 and placebo. However, when looking at the inattentive type of ADHD, 41% of those who took NS2359 had an [...]